- Home
- CDNA vs EYPT Comparison
CDNA vs EYPT Comparison
Compare CDNA & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- EYPT
- Stock Information
- Founded
- CDNA 1998
- EYPT 1987
- Country
- CDNA United States
- EYPT United States
- Employees
- CDNA N/A
- EYPT N/A
- Industry
- CDNA Medical Specialities
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- CDNA Health Care
- EYPT Industrials
- Exchange
- CDNA Nasdaq
- EYPT Nasdaq
- Market Cap
- CDNA 712.2M
- EYPT 741.0M
- IPO Year
- CDNA 2014
- EYPT 2005
- Fundamental
- Price
- CDNA $13.82
- EYPT $14.01
- Analyst Decision
- CDNA Buy
- EYPT Strong Buy
- Analyst Count
- CDNA 7
- EYPT 6
- Target Price
- CDNA $27.67
- EYPT $25.83
- AVG Volume (30 Days)
- CDNA 1.5M
- EYPT 708.2K
- Earning Date
- CDNA 11-03-2025
- EYPT 11-06-2025
- Dividend Yield
- CDNA N/A
- EYPT N/A
- EPS Growth
- CDNA N/A
- EYPT N/A
- EPS
- CDNA 1.00
- EYPT N/A
- Revenue
- CDNA $340,826,000.00
- EYPT $51,898,000.00
- Revenue This Year
- CDNA $13.02
- EYPT N/A
- Revenue Next Year
- CDNA $12.85
- EYPT N/A
- P/E Ratio
- CDNA $13.85
- EYPT N/A
- Revenue Growth
- CDNA 14.72
- EYPT 2.99
- 52 Week Low
- CDNA $10.96
- EYPT $3.91
- 52 Week High
- CDNA $32.97
- EYPT $14.37
- Technical
- Relative Strength Index (RSI)
- CDNA 54.96
- EYPT 77.25
- Support Level
- CDNA $12.37
- EYPT $11.38
- Resistance Level
- CDNA $14.20
- EYPT $12.24
- Average True Range (ATR)
- CDNA 0.73
- EYPT 0.74
- MACD
- CDNA 0.27
- EYPT 0.13
- Stochastic Oscillator
- CDNA 87.02
- EYPT 89.80
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.